|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 403/12 | (2006.01) |
| A61K 31/4184 | (2013.01) | ||
| A61K 31/517 | (2006.01) | ||
| A61K 31/4985 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| C07D 403/12 | (2013.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/517 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 35/04 | (2018.01) |
| (11) | Patento numeris | 3342770 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17179729.3 |
| Europos patento paraiškos padavimo data | 2014-03-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-07-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-03-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| PCT/CN2013/072250 | 2013-03-06 | WO |
| (72) |
LI, David, Yunzhi , CN
WANG, Jiabing , CN
YANG, Zhenfan , CN
ZENG, Qinbei , CN
ZHANG, Xiaolin , CN
|
| (73) |
AstraZeneca AB ,
151 85 Södertälje,
SE
|
| (54) | QUINAZOLINE INHIBITORS OF ACTIVATING MUTANT FORMS OF EPIDERMAL GROWTH FACTOR RECEPTOR |
| QUINAZOLINE INHIBITORS OF ACTIVATING MUTANT FORMS OF EPIDERMAL GROWTH FACTOR RECEPTOR |